Trans-Hit Biomarkers - ImaProteome
Mass Spectrometry, Biomarkers
MALDI-Imaging Mass Spectrometry technology developed by ImaBiotech allows to generate molecular images and to quantify the distribution of molecules in complex samples such as organs, tissues and biopsies, without labeling, extraction/purification and degradation. It has the benefit to in-situ characterize and measure biomarkers, while determining their specific cellular and tissue localizations. Via automation and data processing, molecular maps of molecules can be easily generated from tissue sections collected from patients with cancer, CNS diseases, and many other diseases.
, Mass Spectrometry